세계의 세포 동결 배지 시장 보고서(2025년)
Cell Freezing Media Global Market Report 2025
상품코드 : 1889331
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,559,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,481,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,403,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포 동결 배지 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 15억 9,000만 달러로 평가되었고, 2025년에는 17억 7,000만 달러에 달할 것으로 추정되며, CAGR 11.5%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 바이오 의약품 수요 증가, 세포 기반 요법에 대한 주목 증가, 줄기 세포 은행 활동의 급증, 초대 세포를 이용한 임상 연구 확대, 재생 의료에 대한 정부 자금 증가 등이 요인으로 생각됩니다.

세포 동결 배지 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 27억 달러에 달할 것으로 예측되며, CAGR 11.1%로 성장할 전망입니다. 예측 기간의 성장 요인으로는 세포 및 유전자 치료 개발에 대한 투자 증가, 맞춤형 의료 용도에 대한 주목 증가, 고품질의 세포 보존 솔루션에 대한 수요 증가, 신흥 지역에서의 바이오뱅킹 구상 급증, 만성 질환 및 유전성 질환의 유병률 상승 등을 들 수 있습니다. 예측 기간 주요 동향으로는 무혈청 및 화학적으로 정의된 동결 배지의 기술적 진보, 세포 독성을 저감하는 동결 보호제의 처방 개량, 자동화 및 폐쇄계 동결 프로세스의 혁신, 제어 동결 및 프로그램 동결 장치 개발, 프로세스 최적화를 위한 인공지능 통합 진전 등을 들 수 있습니다.

맞춤형 의료에 대한 수요 증가는 향후 세포 동결 배지 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 치료 성과를 최적화하고 치료를 개선하기 위해 환자의 유전적 요인, 환경 요인, 생활 습관에 따라 치료를 개별화하는 의료 접근법입니다. 유전체 기술의 진보로 유전적 변이의 정밀한 식별 및 개인에 맞춘 치료가 가능하게 됨으로써 맞춤형 의료에 대한 수요가 증가하고 있습니다. 세포 동결 배지는 환자 고유의 세포, 조직, 생물학적 제제를 보존하는 신뢰성이 높은 동결 보존 솔루션을 제공함으로써 맞춤형 의료를 지원합니다. 해동 후의 높은 생존율 및 기능성을 확보해, 맞춤형 치료법의 개발을 지원하는 것과 동시에, 치료 성과의 향상에 공헌합니다. 예를 들어 미국 비영리 단체인 '맞춤형 의료연합(PMC)'에 따르면 2024년 2월 현재 미국 식품의약국(FDA)은 2023년 26건의 새로운 맞춤형 의료를 승인했습니다. 이는 2022년 12건에서 상당한 증가입니다. 따라서 맞춤형 의료에 대한 수요가 증가함에 따라 세포 동결 배지 시장의 성장이 이어지고 있습니다.

세포 동결 배지 시장에서 사업을 전개하는 주요 기업은 효율성 향상, 세포 생존율 향상, 치료 개발 가속을 목적으로 한 특수 동결 배지 등의 선진적인 제품 개발에 주력하고 있습니다. 특수 동결 배지는 세포, 조직 또는 생물학적 물질을 극저온에서 보관하면서 생존율, 기능성, 구조적 무결성을 유지하도록 설계된 준비 용액을 말합니다. 예를 들어, 2024년 4월에는 미국 생명공학 기업인 Pluristyx Inc.가 'PluriFreeze'를 발표했습니다. 이것은 이종 유래 성분이 없고 혈청이 없는 cGMP 제조 배지이며 줄기 세포 및 면역 세포를 포함한 다양한 세포 종의 동결 융해 후 회복률과 기능성 향상을 목적으로 합니다. 높은 세포 생존율 및 기능성을 보장하는 견고하고 즉각적인 제형으로 설계되어 치료법의 조사 단계에서 임상 용도로의 전환을 지원합니다. PluriFreeze는 줄기 세포 및 세포 치료 개발 과정에서 해동 후 세포 생존율, 생산 효율, 재현성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Cell freezing media is a specialized solution used to preserve living cells at very low temperatures, usually in liquid nitrogen, to maintain their viability and functionality for long periods. It typically contains cryoprotective agents that stop ice crystal formation and protect cell integrity during the freezing and thawing process. This media enables long term storage of biological samples for research, therapeutic, or diagnostic purposes, ensuring that cells remain healthy and usable after thawing.

The main types of cell freezing media include dimethyl sulfoxide (DMSO), glycerol, sucrose, ficoll, and serum based media. Dimethyl sulfoxide (DMSO) is an organic solvent commonly used as a cryoprotectant in cell freezing media to prevent ice crystal formation and support cell viability during cryogenic storage. The different cell culture types involved are suspension cell culture, 2D cell culture, 3D cell culture, and others and are distributed through various channels including direct sales, distributors, ecommerce platforms, retail outlets, and specialized scientific instrumentation suppliers. It is used in stem cell research, embryonic cell preservation, hematopoietic cell preservation, tissue sample storage, and gene therapy applications, and serves several end users such as academic research institutions, biotechnology companies, pharmaceutical companies, clinical laboratories, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cell freezing media market research report is one of a series of new reports from The Business Research Company that provides cell freezing media market statistics, including the cell freezing media industry global market size, regional shares, competitors with the cell freezing media market share, detailed cell freezing media market segments, market trends, and opportunities, and any further data you may need to thrive in the cell freezing media industry. This cell freezing media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell freezing media market size has grown rapidly in recent years. It will grow from $1.59 billion in 2024 to $1.77 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising demand for biopharmaceuticals, increasing focus on cell based therapies, a surge in stem cell banking activities, expansion of clinical research involving primary cells, and rising government funding for regenerative medicine.

The cell freezing media market size is expected to see rapid growth in the next few years. It will grow to $2.70 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising investments in cell and gene therapy development, increasing emphasis on personalized medicine applications, growing need for high quality cell storage solutions, surge in biobanking initiatives across emerging regions, and rising prevalence of chronic and genetic disorders. Major trends in the forecast period include technological advancements in serum free and chemically defined freezing media, progress in cryoprotectant formulations to reduce cell toxicity, innovations in automation and closed system freezing processes, developments in controlled rate and programmable freezing equipment, and advancements in the integration of artificial intelligence for process optimization.

The rising demand for personalized medicine is expected to propel the growth of the cell freezing media market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Cell freezing media supports personalized medicine by providing reliable cryopreservation solutions that preserve patient specific cells, tissues, and biologics. It ensures high post thaw viability and functionality, supporting the development of tailored therapies and improving treatment outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition PMC, a US based nonprofit organization, the United States Food and Drug Administration approved twenty six new personalized medicines in 2023, a significant increase from the twelve approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the cell freezing media market.

Major companies operating in the cell freezing media market are focusing on developing advanced products such as specialized cryopreservation media to boost efficiency, enhance cell viability, and accelerate therapeutic development. Specialized cryopreservation media refer to formulated solutions designed to preserve cells, tissues, or biological materials at very low temperatures while maintaining their viability, functionality, and structural integrity. For instance, in April 2024, Pluristyx Inc., a US based biotechnology company, launched PluriFreeze. It is a xeno free and serum free cGMP manufactured media designed to improve post thaw recovery and function of a wide range of cell types including stem cells and immune cells. It is engineered to provide a robust, ready to use formulation that ensures high cell viability and functionality, supporting the transition of therapies from research to clinical application. PluriFreeze improves post thaw cell viability, manufacturing efficiency, and reproducibility in stem cell and cell therapy development processes.

In April 2025, BioLife Solutions Inc., a US based biotechnology company, acquired PanTHERA CryoSolutions Inc. for an undisclosed amount. With this acquisition, BioLife Solutions gains access to PanTHERA's proprietary ice recrystallization inhibitor IRI technology, thereby enhancing its cryopreservation media portfolio while improving product performance, research reach, and customer value in cell and gene therapy biomanufacturing. PanTHERA CryoSolutions Inc. is a Canada based biotechnology company specializing in the development and manufacture of cell freezing media and cryopreservation solutions.

Major companies operating in the cell freezing media market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, FUJIFILM Corporation, Lonza Group Ltd., Avantor Inc., Sartorius AG., BioRad Laboratories Inc., Diploma plc, BioTechne Corporation, Miltenyi Biotec GmbH, Stemcell Technologies Inc., Vitrolife AB, American Type Culture Collection (ATCC), Bio-Life Solutions Inc., Nacalai Tesque Inc., PromoCell GmbH, Nippon Genetics Co. Ltd., Nippon Zenyaku Kogyo Co. Ltd., Quality Biological Inc.

North America was the largest region in the cell freezing media market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell freezing media report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell freezing media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell freezing media market consists of sales of cryovials, freezing containers, cryogenic storage bags, controlled-rate freezers, cryopreservation buffers, and freezing solution kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Freezing Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell freezing media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell freezing media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell freezing media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cell Freezing Media Market Characteristics

3. Cell Freezing Media Market Trends And Strategies

4. Cell Freezing Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Freezing Media Growth Analysis And Strategic Analysis Framework

6. Cell Freezing Media Market Segmentation

7. Cell Freezing Media Market Regional And Country Analysis

8. Asia-Pacific Cell Freezing Media Market

9. China Cell Freezing Media Market

10. India Cell Freezing Media Market

11. Japan Cell Freezing Media Market

12. Australia Cell Freezing Media Market

13. Indonesia Cell Freezing Media Market

14. South Korea Cell Freezing Media Market

15. Western Europe Cell Freezing Media Market

16. UK Cell Freezing Media Market

17. Germany Cell Freezing Media Market

18. France Cell Freezing Media Market

19. Italy Cell Freezing Media Market

20. Spain Cell Freezing Media Market

21. Eastern Europe Cell Freezing Media Market

22. Russia Cell Freezing Media Market

23. North America Cell Freezing Media Market

24. USA Cell Freezing Media Market

25. Canada Cell Freezing Media Market

26. South America Cell Freezing Media Market

27. Brazil Cell Freezing Media Market

28. Middle East Cell Freezing Media Market

29. Africa Cell Freezing Media Market

30. Cell Freezing Media Market Competitive Landscape And Company Profiles

31. Cell Freezing Media Market Other Major And Innovative Companies

32. Global Cell Freezing Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Freezing Media Market

34. Recent Developments In The Cell Freezing Media Market

35. Cell Freezing Media Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기